Opus Genetics, Inc. (IRD): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2009-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$100.0K
Year ended 2009-12-31
Period endedCost of RevenueChange YoYSource filing
2009-12-31$100.0Kn/a2019-03-07, From 2009-01-01